1719 Epizód

  1. Reaffirmation of Mechanistic Proteomic Signatures Accompanying SGLT2 Inhibition in Heart Failure: a EMPEROR Validation Cohort

    Közzétéve: 2024. 11. 04.

  2. JACC - November 12, 2024 Issue Summary

    Közzétéve: 2024. 11. 04.

  3. Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs. Second-Generation DES: TARGET-IV NA Trial

    Közzétéve: 2024. 10. 30.

  4. Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial

    Közzétéve: 2024. 10. 30.

  5. Drug-Coated Balloon Angioplasty Of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial

    Közzétéve: 2024. 10. 28.

  6. Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD

    Közzétéve: 2024. 10. 28.

  7. Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Közzétéve: 2024. 10. 28.

  8. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

    Közzétéve: 2024. 10. 28.

  9. Standard of Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM

    Közzétéve: 2024. 10. 28.

  10. Family Screening in Hypertrophic Cardiomyopathy - Identification of Relatives with Low Yield from Systematic Follow-up

    Közzétéve: 2024. 10. 28.

  11. JACC - November 5, 2024 Issue Summary

    Közzétéve: 2024. 10. 28.

  12. Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results from SEQUOIA-HCM

    Közzétéve: 2024. 10. 28.

  13. Effect of Aficamten on Cardiac Structure and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy

    Közzétéve: 2024. 10. 28.

  14. Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry

    Közzétéve: 2024. 10. 27.

  15. Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-year Outcomes From the TRILUMINATE Randomized Cohort

    Közzétéve: 2024. 10. 27.

  16. Aspirin Hypersensitivity in Patients with Atherosclerotic Cardiovascular Disease

    Közzétéve: 2024. 10. 21.

  17. JACC - October 29, 2024 Issue Summary

    Közzétéve: 2024. 10. 21.

  18. Asymptomatic versus symptomatic hypotension with sacubitril/valsartan in heart failure and reduced ejection fraction in PARADIGM-HF

    Közzétéve: 2024. 10. 21.

  19. The IRONMAN trial of intravenous iron for heart failure. Adjudication of hospitalizations and deaths.

    Közzétéve: 2024. 10. 21.

  20. FcγRIIa: A Marker of Cardiovascular Risk after Myocardial Infarction

    Közzétéve: 2024. 10. 21.

13 / 86

Each week, Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition from the Journal of the American College of Cardiology (JACC), as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer-reviewed journals in the world for scientific impact.

Visit the podcast's native language site